One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Maintaining momentum on gender equity
doi : 10.1016/S2665-9913(23)00193-5
Volume 5, Issue 8, August 2023, Page e427
Obexelimab in IgG4-related disease: B-cell inhibition as a novel therapeutic approach
Tobias Alexander a b c d, Gerd R Burmester a b c
Fatigue in patients with ANCA-associated vasculitis: is avacopan the answer?
Jan Willem Cohen Tervaert a b
Predicting COVID-19 vaccination response in populations who are immunosuppressed
doi : 10.1016/S2665-9913(23)00185-6
Volume 5, Issue 8, August 2023, Pages e431-e432
Ultrasound: a tool to quantify calcium pyrophosphate deposits
Augustin Latourte a b, Pascal Richette a b
The impact of COVID-19 on rheumatology health-care workers and their scientific output: heavy lies the crown on women in rheumatology
doi : 10.1016/S2665-9913(23)00187-X
Volume 5, Issue 8, August 2023, Pages e434-e436
Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?
Doortje I Krijbolder a, Hido D Boom b, Annette H M van der Helm-van Mil a c
Correction to Lancet Rheumatol 2023; 5: e386–400
doi : 10.1016/S2665-9913(23)00182-0
Volume 5, Issue 8, August 2023, Page e440
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial
Cory A Perugino DO a b, Zachary S Wallace MD a, Debra J Zack MD c, Shauna M Quinn PhD d, Allen Poma MD d, Ana D Fernandes MA a, Paul Foster MD c, Steve DeMattos BS c, Bart Burington PhD c, Hang Liu MD b, Hugues Allard-Chamard MD e, Nathan Smith BS f, Xin Kai PhD b, Kelly Xing MD b, Prof Shiv Pillai MBBS b, Prof John H Stone MD a
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
Prof Vibeke Strand MD a, Prof David R W Jayne MD b, Audra Horomanski MD a, Huibin Yue PhD c, Pirow Bekker MD c, Prof Peter A Merkel MD d
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY
doi : 10.1016/S2665-9913(23)00160-1
Volume 5, Issue 8, August 2023, Pages e461-e473
Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level
Silvia Sirotti MD a, Prof Lene Terslev MD b c, Emilio Filippucci MD d, Prof Annamaria Iagnocco MD e, Ingrid Moller MD f, Esperanza Naredo MD g h, Prof Florentin A Vreju MD i, Antonella Adinolfi MD j, Fabio Becce MD k, Prof Hilde Berner Hammer MD m n, Tomas Cazenave MD o, Edoardo Cipolletta MD d, Sara Nysom Christiansen MD b, Andrea Delle Sedie MD p, Mario Diaz MD q, Fabiana Figus MD r, Peter Mandl MD s, Daryl MacCarter MD t, Prof Mohamed A Mortada MD u, Gael Mouterde MD v…Georgios Filippou MD a
Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis
doi : 10.1016/S2665-9913(23)00128-5
Volume 5, Issue 8, August 2023, Pages e483-e494
